Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A.P. (Geke) Hospers

Publicaties

Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study

A prediction model for response to immune checkpoint inhibition in advanced melanoma

BRAF/MEK inhibitor rechallenge in advanced melanoma patients

Comment on the RAPIDO Trial Point-Counterpoint Debate

Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer

Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma

Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by 18 F-BMS986-192 PET: Pooled analysis of data from four solid tumor types

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

Lees meer

Pers/media

‘Het mooie is dat je het microbioom kunt veranderen’

Darmflora beïnvloedt effectiviteit immunotherapie bij huidkanker

Effectiviteit darmflora beïnvloed immunotherapie bij huidkanker

Newly Approved PET Imaging Agent Solves Clinical Dilemmas in Breast Cancer Patients

Lees meer